Zyngenia Attracts NEA. 11/4/2009 Private Placement.

Thomson recorded this investment at only $3M.  The press release clearly stated that it was the full $10M.  Either amount falls below the normal threshold for the mighty NEA.  More than likely, if this early stage investment in a Biotech company focused on cancer and autoimmune disorders works, then there will many more calls for capital.  It warms the heart to see NEA takes chances and invest its fair share in companies in its home market.  It would be a stretch to label NEA as an altruistic enterprise, but there is a long and rich history of partners supporting the local investment community as well as being proactive in investing in their backyard.

This entry was posted in Deal Notes and tagged , , , . Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>


  • The Black & Decker Commentaries

    For the complete, downloadable commentaries on the sale of Black & Decker to The Stanley Works, see the Commentaries tab above.

  • Comments to Chessiecap are Welcome

    Click on PRIVATE COMMENTS tab above.